Viewing data from:

ACETYLCYSTEINE

ANDA

ACETYLCYSTEINE | A203853 | ALVOGEN INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$2.28

per ml

Lowest NADAC/Unit

$0.7201

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
63323069404ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)	$2.28	ML	Generic	—	2026-06-17
63323069444ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)	$2.28	ML	Generic	—	2026-06-17
63323069030ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)	$0.7201	ML	Generic	—	2026-06-17
63323069044ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)	$0.7201	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs

7 active API suppliers hold Drug Master Files for this ingredient.

FIS FABBRICA ITALIANA SINTETICI SPAACETYLCYSTEINE, USP

DMF 50911983

MOEHS IBERICA SLACETYLCYSTEINE USP

DMF 143041999

NIPPON RIKA CO LTDACETYLCYSTEINE DRUG SUBSTANCE

DMF 217892008

FUJIAN SOUTH PHARMACEUTICAL CO LTDACETYLCYSTEINE

DMF 379472023

ZHEJIANG JINHUA CONBA BIO-PHARM CO LTDACETYLCYSTEINE (USP)

DMF 402482024

SHANXI YANGHE PHARMACEUTICAL CO LTDACETYLCYSTEINE

DMF 415912025

ZHEJIANG HAIZHOU PHARMACEUTICAL CO LTDACETYLCYSTEINE

DMF 428222025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 20%

0 patents0 exclusivities▴

SOLUTION;INHALATION, ORAL | Approved: Jun 21, 2012

No patent or exclusivity listings for this strength.